AR203627A1 - Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico - Google Patents

Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico

Info

Publication number
AR203627A1
AR203627A1 AR249382A AR24938273A AR203627A1 AR 203627 A1 AR203627 A1 AR 203627A1 AR 249382 A AR249382 A AR 249382A AR 24938273 A AR24938273 A AR 24938273A AR 203627 A1 AR203627 A1 AR 203627A1
Authority
AR
Argentina
Prior art keywords
ilacetico
heterociclico
indol
synthesis
acid
Prior art date
Application number
AR249382A
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of AR203627A1 publication Critical patent/AR203627A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR249382A 1971-11-03 1973-07-31 Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico AR203627A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
AR203627A1 true AR203627A1 (es) 1975-09-30

Family

ID=27257588

Family Applications (3)

Application Number Title Priority Date Filing Date
AR244863A AR198064A1 (es) 1971-11-03 1972-10-27 Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico
AR249381A AR203626A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos acidos heterociclico-indol-3-ii-acetic
AR249382A AR203627A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AR244863A AR198064A1 (es) 1971-11-03 1972-10-27 Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico
AR249381A AR203626A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos acidos heterociclico-indol-3-ii-acetic

Country Status (17)

Country Link
US (1) US3884919A (es)
JP (1) JPS4856667A (es)
AR (3) AR198064A1 (es)
BE (1) BE790679A (es)
CA (1) CA983932A (es)
CH (1) CH577499A5 (es)
DD (1) DD105611A5 (es)
DE (1) DE2253927A1 (es)
EG (1) EG11358A (es)
ES (2) ES408226A1 (es)
FR (1) FR2158464B1 (es)
GB (1) GB1356834A (es)
HU (1) HU169711B (es)
IE (1) IE37998B1 (es)
IL (1) IL40521A (es)
NL (1) NL7214807A (es)
SE (1) SE384856B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
AU686843B2 (en) * 1994-02-23 1998-02-12 Pfizer Inc. 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
NZ506329A (en) * 1998-02-25 2004-01-30 Inst Genetics Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
ES2257616T3 (es) 2003-04-25 2006-08-01 Actimis Pharmaceuticals, Inc. Derivados del acido pirimidinilacetico utiles para el tratamiento de enfermedades mediadas por crth2.
CA2524221A1 (en) * 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
RU2373208C2 (ru) 2004-01-31 2009-11-20 Актимис Фармасьютикалз, Инк. Производные имидазо[1,2-c]пиримидинилуксусной кислоты
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
JP5208510B2 (ja) 2004-11-23 2013-06-12 アストラゼネカ・アクチエボラーグ 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
CN102558021A (zh) 2006-05-26 2012-07-11 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
US7999119B2 (en) 2006-07-22 2011-08-16 Oxagen Limited Compounds having CRTH2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
ATE547407T1 (de) 2007-09-25 2012-03-15 Actimis Pharmaceuticals Inc Alkylthiopyrimidine als crth2-antagonisten
TW200920373A (en) 2007-09-25 2009-05-16 Actimis Pharmaceuticals Inc 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
MX2010007833A (es) 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509990A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CA3114672A1 (en) * 2018-10-05 2020-04-23 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (es) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
BE790679A (fr) 1973-04-27
FR2158464B1 (es) 1976-07-02
ES437311A1 (es) 1977-04-01
CH577499A5 (es) 1976-07-15
ES408226A1 (es) 1976-02-01
SE384856B (sv) 1976-05-24
AR198064A1 (es) 1974-05-31
FR2158464A1 (es) 1973-06-15
DD105611A5 (es) 1974-05-05
GB1356834A (en) 1974-06-19
US3884919A (en) 1975-05-20
CA983932A (en) 1976-02-17
DE2253927A1 (de) 1973-05-10
HU169711B (es) 1977-02-28
IL40521A (en) 1975-06-25
EG11358A (en) 1977-02-28
IE37998B1 (en) 1977-12-07
AR203626A1 (es) 1975-09-30
IE37998L (en) 1973-05-03
IL40521A0 (en) 1972-12-29
JPS4856667A (es) 1973-08-09
NL7214807A (es) 1973-05-07

Similar Documents

Publication Publication Date Title
AR203627A1 (es) Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico
IT972657B (it) Produzione di composti polifunzionali
IT973901B (it) Procedimento per la produzione di alogenidrine
IT964102B (it) Preparazione d acido gliossilico
AR213059A1 (es) Procedimiento de preparacion de derivados de acido 7-acilaminocefalosporanico
SE414304B (sv) Estrar av cyklopropankarboxylsyraderivat for pesticidiskt bruk
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE406762B (sv) Forfarande for framstellning av prostansyraderivat
NO137318C (no) Fremgangsm}te for kontinuerlig fremstilling av natriumperkarbonat
IT958044B (it) Procedimento per la produzione di politiobisfenoli
GB1406621A (en) Derivatives of prostanoic acid
AR192879A1 (es) Preparacion de compuestos de acido 7-amino-cef-3-em-4-carboxilico
AR196987A1 (es) Procedimiento para la preparacion de nuevos derivados del acido 7-amino-cefaloesporanico
RO71183A (ro) Procedeu de prepararea 20-on-steroidelor substituite
BE786416A (fr) Production de tetramisoles
IT1002168B (it) Preparazione d acido gliossilico
AR202261A1 (es) Procedimiento para preparar derivados del acido 7-amino-3-mercaptometil-cefalosporanico
IT947739B (it) Produzione di ferriti
BE777764A (fr) Production de composes de methyl-etain
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
SE394660B (sv) Forfarande for framstellning av svavelsyra
IT954173B (it) Procedimento per la produzione di acido tetronico
SE384381B (sv) Forfarande for kontinuerlig framstellning av ferrokisel
JPS537675A (en) Production of xantonecarboxylic acid derivatives
PH10267A (en) New derivatives of 4-chloro-5-sulfamoyl-anthranilic acid